Adenovirus-mediated suicide gene therapy for experimental bladder cancer
- 28 February 1997
- Vol. 49 (2) , 173-180
- https://doi.org/10.1016/s0090-4295(96)00560-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Adenoviral - P53 Gene Transfer to Orthotopic and Peritoneal Murine Bladder CancerJournal of Urology, 1996
- Gene therapy for urologic cancerUrology, 1994
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- The Basic Science of Gene TherapyScience, 1993
- Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.The Journal of Experimental Medicine, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer, 1989
- Antiviral Activity and Mechanism of Action of GanciclovirClinical Infectious Diseases, 1988
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- A Review of Adenoviruses in the Etiology of Acute Hemorrhagic CystitisJournal of Urology, 1976